Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Evotec SE (EVO) over the last 7 years, with Dec 2024 value amounting to $424.0 million.

  • Evotec SE's Cash & Equivalents fell 19.90% to $203,460 in Q3 2025 from the same period last year, while for Sep 2025 it was $203,460, marking a year-over-year decrease of 19.90%. This contributed to the annual value of $424.0 million for FY2024, which is 34.77% down from last year.
  • As of FY2024, Evotec SE's Cash & Equivalents stood at $424.0 million, which was down 34.77% from $650.0 million recorded in FY2023.
  • In the past 5 years, Evotec SE's Cash & Equivalents ranged from a high of $800.0 million in FY2021 and a low of $423.6 million during FY2022.
  • In the last 3 years, Evotec SE's Cash & Equivalents had a median value of $424.0 million in 2024 and averaged $499.2 million.
  • Per our database at Business Quant, Evotec SE's Cash & Equivalents skyrocketed by 62.39% in 2020 and then plummeted by 47.06% in 2022.
  • Over the past 5 years, Evotec SE's Cash & Equivalents (Yearly) stood at $503.8 million in 2020, then soared by 58.78% to $800.0 million in 2021, then slumped by 47.06% to $423.6 million in 2022, then soared by 53.46% to $650.0 million in 2023, then tumbled by 34.77% to $424.0 million in 2024.